Keyphrases
Parkinson's Disease
100%
Alpha-synuclein (α-syn)
100%
Saliva
100%
Disease Pattern
100%
Cerebrospinal Fluid
100%
β-amyloid1-42
25%
Motor Phenotype
25%
CSF Biomarkers
25%
Biofluids
16%
Idiopathic Rapid Eye Movement Sleep Behavior Disorder (iRBD)
16%
Healthy Controls
16%
Advanced PD
16%
Montreal Cognitive Assessment (MoCA)
16%
Cognitive Impairment
8%
Clinical Features
8%
Imaging Biomarkers
8%
Amyloid beta
8%
Potential Biomarkers
8%
Clinical Characteristics
8%
Motor Symptoms
8%
Cross-sectional Observational Study
8%
Unified Parkinson's Disease Rating Scale (UPDRS)
8%
Phosphorylated tau
8%
Non-motor Symptoms
8%
Biomarker Characteristics
8%
Total tau
8%
Recall Score
8%
Postural Instability Gait Difficulty
8%
Diagnosis Biomarker
8%
Diagnosis Phenotypes
8%
Biofluid Biomarkers
8%
Neuroscience
Parkinson's Disease
100%
Alpha-Synuclein
100%
Blood Plasma
100%
Rapid Eye Movement Sleep Behavior Disorder
16%
Cognitive Disorders
8%
Beta Amyloid
8%
Biochemistry, Genetics and Molecular Biology
Alpha-Synuclein
100%
Blood Plasma
100%
Tau
25%
REM Sleep
16%
Observational Study
8%
Amyloid Beta
8%